John Y. Wang

发表

Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.

M. Warmuth, Shouyong Peng, K. Kunii, 2015, Cell reports.

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.

Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell line.

M. Hao, M. Warmuth, Peter G. Smith, 2014, Organic letters.

E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity

M. Hao, N. Sarwar, K. Loiacono, 2021, ChemMedChem.

Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWTand ERaMUTbreast cancer

M. Hao, M. Warmuth, M. Korpal, 2021 .

Pharmacological Activation of STING in Bladder Induces Potent Anti-tumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.

J. Hutz, Chi Zhang, D. Verbel, 2022, Molecular cancer therapeutics.

Abstract 4456: Discovery of E7766: A representative of a novel class of macrocycle-bridged STING agonists (MBSAs) with superior potency and pan-genotypic activity

M. Hao, N. Sarwar, K. Loiacono, 2019, Cancer Chemistry.

Correction: Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.

J. Hutz, D. Chandra, D. Verbel, 2023, Molecular cancer therapeutics.

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.